Business ❯Mergers and Acquisitions ❯Pharmaceutical Industry ❯Cancer Treatments

Ovarian Cancer Treatments

AbbVie Acquires ImmunoGen for $10.1 Billion, Gaining Access to Promising Ovarian Cancer Drug